Pfizer Merger Hangs Wyeth Investors Out To Dry: Suit
Wyeth Inc. shareholders have filed an amended complaint in their bid to halt a $68 billion merger between Wyeth and pharmaceutical giant Pfizer Inc., claiming the proposed deal isn't in the...To view the full article, register now.
Already a subscriber? Click here to view full article